scholarly journals 664 High-throughput fetal-fraction amplification increases analytical performance of noninvasive prenatal screening

2021 ◽  
Vol 224 (2) ◽  
pp. S417-S418
Author(s):  
Dale Muzzey ◽  
Noah Welker ◽  
Albert Lee ◽  
Rachel Kjolby ◽  
Helen Wan ◽  
...  
2020 ◽  
Author(s):  
Liang Hu ◽  
Yuanyuan Pei ◽  
Xiaojin Luo ◽  
Lijuan Wen ◽  
Hui Xiao ◽  
...  

Abstract Background The study was a retrospective cohort analysis based on the results of noninvasive prenatal screening (NIPS), complete blood count, thyroxin test and Down’s syndrome screening in first or second trimester from 14043 pregnant women. Random forests algorithm was applied to predict the low fetal fraction of cell free DNA (with FF lower than 10th percentile) through individual and laboratory information. Performance of the model was evaluated and compared to prediction using maternal weight.To investigate factors associated with lower FF in the NIPS and to develop a new predictive method for low FF before NIPS. Results Of 14043 cases, maternal weight, RBC, HGB and free T3 were significantly negative correlated with FF while gestation age, free T4, PAPP-A, AFP, uE3 and β-hCG were significantly positive correlated with FF. Compared to prediction using maternal weight as isolated parameter, the model has a higher area under curve(AUC) of Receiver Operating Characteristic (ROC) and overall accuracy. Conclusions The comprehensive predictive method based on combined multiple factors was more effective than single-factor model in low FF status prediction. This method can provide more information for clinical choice and pre-test quality control of NIPS.


Author(s):  
Noah C. Welker ◽  
Albert K. Lee ◽  
Rachel A. S. Kjolby ◽  
Helen Y. Wan ◽  
Mark R. Theilmann ◽  
...  

Abstract Purpose The percentage of a maternal cell-free DNA (cfDNA) sample that is fetal-derived (the fetal fraction; FF) is a key driver of the sensitivity and specificity of noninvasive prenatal screening (NIPS). On certain NIPS platforms, >20% of women with high body mass index (and >5% overall) receive a test failure due to low FF (<4%). Methods A scalable fetal fraction amplification (FFA) technology was analytically validated on 1264 samples undergoing whole-genome sequencing (WGS)–based NIPS. All samples were tested with and without FFA. Results Zero samples had FF < 4% when screened with FFA, whereas 1 in 25 of these same patients had FF < 4% without FFA. The average increase in FF was 3.9-fold for samples with low FF (2.3-fold overall) and 99.8% had higher FF with FFA. For all abnormalities screened on NIPS, z-scores increased 2.2-fold on average in positive samples and remained unchanged in negative samples, powering an increase in NIPS sensitivity and specificity. Conclusion FFA transforms low-FF samples into high-FF samples. By combining FFA with WGS–based NIPS, a single round of NIPS can provide nearly all women with confident results about the broad range of potential fetal chromosomal abnormalities across the genome.


2019 ◽  
Vol 40 (2) ◽  
pp. 179-184 ◽  
Author(s):  
Herman Hedriana ◽  
Kimberly Martin ◽  
Daniel Saltzman ◽  
Paul Billings ◽  
Zachary Demko ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document